(Q45391143)

English

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant

scientific article published on 10 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant (English)

1 reference

Europe PubMed Central

14 December 2017

7

object named as

Jimmy Kwang

1 reference

Europe PubMed Central

14 December 2017

author name string

Mookkan Prabakaran

1

1 reference

Europe PubMed Central

14 December 2017

Sumathy Velumani

2

1 reference

Europe PubMed Central

14 December 2017

Fang He

3

1 reference

Europe PubMed Central

14 December 2017

Anbu K Karuppannan

4

1 reference

Europe PubMed Central

14 December 2017

Grace Yuhong Geng

5

1 reference

Europe PubMed Central

14 December 2017

Lee Ker Yin

6

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

10 September 2008

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

380

1 reference

Europe PubMed Central

14 December 2017

2

1 reference

Europe PubMed Central

14 December 2017

412-420

1 reference

Europe PubMed Central

14 December 2017

Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Live poultry exposures, Hong Kong and Hanoi, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Effects of recombinant cholera toxin B subunit on IL-1beta production by macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Vaccination strategies for mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

The cholera toxin B subunit directly costimulates antigen-primed CD4+ T cells ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Nasal lymphoid tissue (NALT) as a mucosal immune inductive site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

New generation of mucosal adjuvants for the induction of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

Baculovirus stimulates antiviral effects in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2008.08.002

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45391143&oldid=2076352938"